Quantcast
Last updated on April 19, 2014 at 5:20 EDT

Latest Multiple Myeloma Research Foundation Stories

2013-09-18 15:26:41

Findings provide insights for new, targeted cancer therapies in clinical trials Researchers have discovered why multiple myeloma, a difficult to cure cancer of the bone marrow, frequently recurs after an initially effective treatment that can keep the disease at bay for up to several years. Working in collaboration with colleagues at Princess Margaret Hospital in Toronto, researchers from Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) in Phoenix were...

2013-09-13 16:24:03

New survey shows majority of Canadians participate in local fundraising events such as walks MONTREAL, Sept. 13, 2013 /CNW/ - This September, ten cities across Canada will take part in the 5(th) annual Multiple Myeloma March, a national fundraising event that supports multiple myeloma research, advancements in treatment and much-needed patient and caregiver programs in communities across Canada. Driven by patients and their friends and families, the Multiple Myeloma March is...

2013-06-27 23:34:00

Cancer Support Community's expanded Cancer Experience Registry created to identify social and emotional needs of people living with multiple myeloma Washington, D.C. (PRWEB) June 27, 2013 The Cancer Support Community’s Research and Training Institute has added a focus on people living with multiple myeloma to its nationwide Registry today. According to the National Cancer Institute, there will be 22,350 new cases of multiple myeloma diagnosed in the U.S. this year. This type of...

2013-06-20 16:27:27

CAMBRIDGE, Mass., June 20, 2013 /PRNewswire/ -- The White House today recognized John Quackenbush, PhD, founder and Chief Executive Officer of GenoSpace, LLC, as an Open Science "Champion of Change". The program recognizes outstanding individuals, organizations and research projects promoting and using open scientific data and publications to accelerate progress and improve our world. GenoSpace builds information systems capable of storing and integrating genomic information and health data...

2013-03-21 16:24:59

Hematology / oncology industry expert to lead promising development pipeline BOULDER, Colo., March 21, 2013 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, today announced the appointment of Michael N. Needle, M.D., to the position of Chief Medical Officer. Dr. Needle, a board certified hematologist / oncologist, will...

2013-01-25 10:23:12

Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for patients with multiple myeloma who have disease relapsed after treatments with other drugs, such as bortezomib and lenalidomide.  This phase I clinical trial enrolled 38 patients, and pomalidomide provided a minimal or better response for 42 percent of the patients, a partial response or better for 21 percent, and a complete response for 3 percent....

2013-01-03 08:26:29

CAMBRIDGE, Mass., Jan. 3, 2013 /PRNewswire/ -- Epizyme, Inc., a biopharmaceutical company leading the creation of personalized therapeutics to treat patients with genetically defined cancers, today announced that Robert Gould, Ph.D., President and CEO of Epizyme, will present a company overview at the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, January 8 at 8 a.m. PST at the Westin St. Francis Hotel in San Francisco, CA. The presentation will address advances made over the past...

2012-12-07 05:00:49

Mitchell Vazquez, owner of the GCI Financial, makes noble use of his financial success by donating substantial gifts to Multiple Myeloma Research Foundation. This organization is dedicated to finding cures and treatments for certain types of cancer. He supports this cause and helps them make advances in bringing new treatments to patients and extending their lives. New York (PRWEB) December 06, 2012 Mitchell Vazquez, owner of the GCI Financial, makes noble use of his financial success by...

2012-12-06 16:24:09

SOUTH SAN FRANCISCO, Calif., Dec. 6, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced the launch of the Make Your Mark at the Multiple Myeloma Experience at the 54(th) American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, Georgia on December 8, 2012. The experience is designed to celebrate progress made in the treatment of multiple myeloma, an incurable blood cancer, and encourage members of the multiple myeloma community to make their...

2012-11-08 08:35:03

CAMBRIDGE, Mass., BOSTON and NEW YORK, Nov. 8, 2012 /PRNewswire/ -- GNS Healthcare, Inc. (GNS), the leading healthcare data analytics company focused on enabling personalized medicine to improve human health, today announced that it has entered into a collaboration with Dana-Farber Cancer Institute (Dana-Farber) and Mount Sinai School of Medicine (Mount Sinai) to create a data-driven computer model of multiple myeloma, the second most common blood cancer in the U.S. that constitutes...